ABSTRACT
Background Although changes in effective circulatory volume may affect microcirculatory red blood cell (RBC) velocity and oxygen extraction ratio, no systemic variable has been consistently associated with hemodynamic coherence. We therefore evaluated the association between mean circulatory filling pressure and microcirculatory perfusion and oxygenation.
Methods This analysis included anesthetized individuals in steady-state physiology. We assessed the correlation of mean circulatory filling pressure analogue (Pmca) with sublingual microcirculation and RBC velocity using SDF+ imaging and a modified optical flow-based algorithm. We also reconstructed the 2D microvessels and applied Computational Fluid Dynamics (CFD) to evaluate the correlation of Pmca and RBC velocity with the obtained pressure and velocity fields in microvessels from CFD [pressure difference (Δp)].
Results Twenty adults were included in the study, of whom 12 (60%) were men and 8 (40%) were women, with a median age of 39.5 years (IQR 35.5-44.5). Sublingual velocity distributions were similar and followed a log-normal distribution. A constant Pmca value of 14 mmHg was observed in all individuals with sublingual RBC velocity of 6-24 μm sec-1, while a Pmca <14 mmHg was observed in those with RBC velocity >24 μm s-1. When Pmca ranged between 11 mmHg and 15 mmHg, Δp fluctuated between 0.02 Pa and 0.1 Pa.
Conclusions These data suggest that the intact regulatory mechanisms may maintain a physiological coupling between systemic hemodynamics and tissue perfusion and oxygenation when Pmca is 14 mmHg.
HIGHLIGHTS
Changes in effective circulatory volume may affect microcirculatory red blood cell (RBC) velocity and oxygen extraction ratio, but no systemic variable has been consistently associated with hemodynamic coherence
We found that a mean circulatory filling pressure analogue (Pmca) value of 14 mmHg maintains sublingual RBC velocity at 6-24 μm s-1
A Pmca <14 mmHg is observed in individuals with RBC velocity >24 μm s-1
Microvessel pressure difference is maintained constant when Pmca ranges between 11 mmHg and 15 mmHg
These findings imply that tissue oxygenation can be maintained in very low RBC velocities
Therapeutic strategies and translational research beyond optimizing macrohemodynamics and microcirculatory flow are required, including normalizing red blood cell velocity
Background Hemodynamic coherence is not well-investigated and no systemic hemodynamic variable has been consistently correlated with microcirculatory perfusion and tissue oxygenation.
Translational Significance The present study provides a novel method to monitor hemodynamic coherence and tissue perfusion, which can aid in the identification of novel hemodynamic phenotypes and enhance microcirculation-guided therapeutic strategies, optimizing local delivery of oxygen. Our findings also imply that (1) tissue oxygenation can be maintained in very low red blood cell velocities; and (2) therapeutic strategies and translational research beyond optimizing macrohemodynamics and microcirculatory flow are required, including normalizing red blood cell velocity.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The University Hospital of Larisa, Greece, Institutional Review Board gave ethical approval for this work (IRB no. 60580, 11 Dec 2018).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data can be made available upon request after publication through a collaborative process. Researchers should provide a methodically sound proposal with specific objectives in an approval proposal. Please contact the corresponding author for additional information.
